Related Experiment Video
Updated: Nov 8, 2025

Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases
Published on: June 28, 2019
Emerging Role of PD-1 in the Central Nervous System and Brain Diseases
Junli Zhao1, Alexus Roberts2,3, Zilong Wang2
1Department of Anesthesiology, Duke University Medical Center, Durham, 27710, USA. junli.zhao@duke.edu.
Abstract:
Programmed cell death protein 1 (PD-1) is an immune checkpoint modulator and a major target of immunotherapy as anti-PD-1 monoclonal antibodies have demonstrated remarkable efficacy in cancer treatment. Accumulating evidence suggests an important role of PD-1 in the central nervous system (CNS). PD-1 has been implicated in CNS disorders such as brain tumors, Alzheimer's disease, ischemic stroke, spinal cord injury, multiple sclerosis, cognitive function, and pain. PD-1 signaling suppresses the CNS immune response via resident microglia and infiltrating peripheral immune cells. Notably, PD-1 is also widely expressed in neurons and suppresses neuronal activity via downstream Src homology 2 domain-containing protein tyrosine phosphatase 1 and modulation of ion channel function. An improved understanding of PD-1 signaling in the cross-talk between glial cells, neurons, and peripheral immune cells in the CNS will shed light on immunomodulation, neuromodulation, and novel strategies for treating brain diseases.
Insights
Programmed cell death protein 1 (PD-1) impacts the central nervous system (CNS), affecting immune responses and neuronal activity. Understanding PD-1 signaling in the brain offers new therapeutic strategies for neurological disorders.
Area of Science:
- Neuroimmunology
- Neuroscience
- Immunology
Background:
- Programmed cell death protein 1 (PD-1) is a key immune checkpoint target in cancer immunotherapy.
- Emerging evidence highlights PD-1's significant role in central nervous system (CNS) functions and disorders.
- PD-1 influences CNS immunity by modulating microglia and peripheral immune cells.
Purpose of the Study:
- To explore the multifaceted roles of PD-1 signaling within the CNS.
- To investigate PD-1's impact on both immune and neuronal functions in the brain.
- To understand the cross-talk between glial cells, neurons, and immune cells mediated by PD-1.
Main Methods:
- Review of existing literature on PD-1 in CNS disorders.
- Analysis of PD-1 expression in neurons and glial cells.
- Examination of downstream signaling pathways, including protein tyrosine phosphatase 1 and ion channel modulation.
Main Results:
- PD-1 suppresses CNS immune responses.
- PD-1 is expressed in neurons, where it suppresses neuronal activity.
- PD-1 signaling involves glial cells, neurons, and peripheral immune cells.
Conclusions:
- PD-1 plays a dual role in the CNS, affecting both immune and neuronal functions.
- Further understanding of PD-1 signaling in the CNS is crucial for developing novel treatments.
- Targeting PD-1 may offer new therapeutic avenues for brain diseases like tumors, Alzheimer's, and stroke.
Related Concept Videos
The Blood-brain Barrier
EPS and iPS Cells in Disease Research
Parkinson's Disease: Overview
Neural Regulation
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

